Can children with hyperlipidemia receive ketogenic diet for medication-resistant epilepsy?

Journal of Child Neurology

Volumn 28, Issue 4, 2013, Pages 479-483

  Liu, Yeou Mei Christiana ^a   Lowe, Helen ^a   Zak, Maria M ^a   Kobayashi, Jeff ^a   Chan, Valerie W ^a   Donner, Elizabeth J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

hyperlipidemia; ketogenic therapy; low density lipoprotein; total cholesterol; total cholesterol high density lipoprotein.

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; EPILEPSY; FEMALE; HUMAN; HYPERLIPIDEMIA; INFANT; KETOGENIC DIET; LIPOPROTEIN BLOOD LEVEL; MALE; MEDICAL RECORD REVIEW; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ANTICONVULSANTS; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; HUMANS; HYPERLIPIDEMIAS; INFANT; KETOGENIC DIET; LIPID METABOLISM; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84875322653     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073813476140     Document Type: Article

References (18)

1. Kwiterovich PO, Vining EPG, Pyzik P, et al. Effect of a high-fat ketogenic diet on plasma levels of lipids, lipoproteins, and apolipoproteins in children. JAMA. 2003 ; 290: 912-920
2. Nizamuddin J, Turner Z, Rubenstein JE, et al. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol. 2008 ; 23: 758-761
3. Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006 ; 48: 978-981
4. Soldin SJ Pediatric Reference Intervals. 5 th ed. Washington, DC: AACC Press; 2005. Washington, DC: AACC Press ; 2005 :
5. Capuano V, Rocco A, Lmaida N, Capuano E. Management of hypercholesterolemia in children: needs and concerns. G Ital Cardio. 2011 ; 12: 707-716
6. McNeil C, Godwin D, Robinson L, et al. C-b5-03: linking parent and child medical records to identify youth at risk for familial hypercholesterolemia. Clin Med Res. 2011 ; 9: 154
7. Statistics Canada. (n.d.). Heart health and cholesterol levels of Canadians 2007-2009. http://www.statcan.gc.ca/pub/. Accessed October 6, 2011.
8. Health Canada. Fish oil. Drug and Health Products. Health Canada. http://www.hc-sc.gc.ca/dhp-mps/index-eng.php. Accessed February 28, 2012.
9. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011 ; 58: 2047-2067
10. Maki KC, Lawless AL, Kelley KM, et al. Prescription omega-3-acid ethyl esters reduce fasting and postprandial triglycerides and modestly reduce pancreatic β-cell response in subjects with primary hypertriglyceridemia. Prostagl Leuk Essent Fatty Acids. 2011 ; 85: 143-148
11. Cha YS. Effects of l-carnitine on obesity, diabetes, and as an ergogenic aid. Asia Pacif J Clin Nutr. 2008 ; 17 (suppl). S306 - S308
12. Gidding SS. New cholesterol guidelines for children?. Circulation. 2006 ; 114: 989-991
13. 2010 AB
14. Daniels SR. Lipid concentrations in children and adolescents: it is not all about obesity. Am J Clin Nutr. 2011 ; 94: 877-883
15. Daniels SR, Gidding SS, de Ferranti SD. National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011 ; 5: S30 - S37
16. Dashti HM, Mathew TC, Hussein T, et al. Long-term effects of a ketogenic diet in obese patients. Exp Clin Cardiol. 2004 ; 9: 200-205
17. Maqbool A, Olsen IE, Stallings VA Nutrition in Pediatrics: Basic Science, Clinical Applications. 4 th ed. Hamilton: BC Decker Inc; 2008:5-13. Duggan C Watkins JB Walker WA, ed. Hamilton: BC Decker Inc ; 2008: 5-13.
18. Grummer-Strawn LM, Reinold C, Krebs NF. Use of World Health Organization and CDC growth charts for children aged 0-59 months in the United States. MMWR Recomm Rep. 2010 ; 59 (rr09). 1-15